P
Pnina Dorfman-Etrog
Researcher at Rabin Medical Center
Publications - 12
Citations - 668
Pnina Dorfman-Etrog is an academic researcher from Rabin Medical Center. The author has contributed to research in topics: Brief Psychiatric Rating Scale & Schizophrenia. The author has an hindex of 9, co-authored 12 publications receiving 646 citations. Previous affiliations of Pnina Dorfman-Etrog include Tel Aviv University.
Papers
More filters
Journal ArticleDOI
Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study.
Roni Shiloh,Zvi Zemishlany,Dov Aizenberg,Marguerite Radwan,Bruria Schwartz,Pnina Dorfman-Etrog,Ilan Modai,Marina Khaikin,Abraham Weizman +8 more
TL;DR: A subgroup of patients with chronic schizophrenia may substantially benefit from sulpiride addition to clozapine, and exhibited substantially greater and significant improvements in positive and negative psychotic symptoms.
Journal Article
Sexual dysfunction in male schizophrenic patients.
TL;DR: In this paper, the authors evaluated the sexual function of untreated and treated male schizophrenic patients in comparison with healthy subjects, and found that the schizophrenic subjects were more involved in masturbatory activity and more satisfied with their sexual function compared with the control subjects.
Journal ArticleDOI
Abnormal thermoregulation in drug-free male schizophrenia patients.
Roni Shiloh,Abraham Weizman,Yoram Epstein,Sara-Lea Rosenberg,Avi Valevski,Pnina Dorfman-Etrog,Nehama Wiezer,Nachum Katz,Hanan Munitz,Haggai Hermesh +9 more
TL;DR: The schizophrenia patients exhibited significantly higher baseline and exertion-related rectal temperature and the relevance of these findings to the pathophysiology of schizophrenia-related thermoregulatory disorders is as yet unclear.
Journal ArticleDOI
Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms.
Michael Poyurovsky,Pnina Dorfman-Etrog,Haggai Hermesh,Hanan Munitz,G. D. Tollefson,Abraham Weizman +5 more
TL;DR: Preliminary results suggest that olanzapine may be a therapeutic option in schizophrenic patients with obsessive-compulsive symptoms.
Journal ArticleDOI
The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label study.
TL;DR: Addition of vitamin E to neuroleptics may reduce the severity of acute NIP in schizophrenic patients, and is associated with a trend towards prevention of the emergence of NIP compared to Neuroleptic treatment alone.